Classer les publications sur l'année

  • AutresSantĂ© Publique et EpidĂ©miologie

    The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report

    HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.

    Therapie ; 2020;52(4),420-426

  • SantĂ© Publique et EpidĂ©miologie

    The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report.

    HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.

    Digestive and Liver Disease ; 2019

  • Pharmaco-EpidĂ©miologie

    Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting.

    BARBUT F, GALPERINE T, VANHEMS P, LE MONNIER A, DURAND-GASSELIN B, CANIS F, JEANBAT V, DUBURCQ A, ALAMI S, BENSOUSSAN C, FAGNANI F.

    Health Qual Life Outcomes ; 2019;17(1);6

  • Économie de la santĂ©

    Etude pharmaco-économique sur la prise en charge du reflux gastro-oesophagien en France en 2005 en médecine générale

    MOULY S, CHARLEMAGNE A, LE JEUNNE PH, FAGNANI F

    Presse Med ; 37:1397-1406

  • Pharmaco-EpidĂ©miologie

    Irritable bowel syndrome in France : quality of life, medical management, and costs : the Encoli Study

    BRUN-STRANG C, DAPOIGNY M, LAFUMA A, WAINSTEN JP, FAGNANI F

    Eur J Gastroenterol Hepatol ; 19(12):1097-1103

  • Pharmaco-EpidĂ©miologie

    EnquĂȘte nationale sur les pratiques de prophylaxie des hĂ©morragies gastroduodĂ©nales en rĂ©animation

    DHOTE R, DETOURNAY B, SLAMA A, HAMEL L, BIGARD MA, BOLLAERT PE, COLIN R, FAGON JY, LE GALL JR, RAPHAEL JC

    RĂ©animation Urgences ; 2000;9(7):550-554

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis

    BARBUT F, BOUEE S, LONGEPIERRE L, GOLDBERG M, BENSOUSSAN C, LEVY-BACHELOT L

    J Hosp Infect ; 2017;98(1):21-28

  • Pharmaco-EpidĂ©miologie

    Infliximab Paediatric Crohn’s Disease Educational Plan : A European, Cross-Sectional, Multicentre Evaluation

    ARANA A, ALLEN S, BURKOWITZ J, FANTONI V, GHATNEKAR O, RICO MT, VANHAVERBEKE N, WENTWORTH CE, BROSA M, ARELLANO F

    Drug Saf ; 2010;33(6):489-501